Glidden R S, Mantzouranis E C, Borel Y
Clin Immunol Immunopathol. 1983 Nov;29(2):196-210. doi: 10.1016/0090-1229(83)90024-7.
A retrospective review of 55 patients with systemic lupus erythematosus (SLE) (45 girls and 10 boys) under age 18 (median age of onset; 12.2 years) seen at the Children's Hospital Medical Center (Boston, Mass.) over the past 20 years was done. Clinical presentation was similar to previous series, but atypical presentation was common. Certain unusual presentations (such as isolated hematopoietic abnormalities) often occurred and delayed diagnosis for years in some cases. The frequency of ARA clinical classification of SLE was different in children as compared to adults. We observed depression of lymphocyte count in many patients and encountered elevations of hepatic enzyme levels in others. Of the 55 patients reviewed, 9 have died and 8 have been lost to follow-up. Of the rest, 21 have mild to moderate disease and 17 have inactive or minimally active SLE, after a median length of follow-up of 8.8 years. In severe cases, using either corticosteroids and/or cytotoxic agents, a favorable prognosis was obtained. Our cumulative 5- and 10-year survival of 92 and 85%, respectively, equals or exceeds that of previous reports of childhood SLE.
对过去20年在波士顿儿童医院医疗中心就诊的55例18岁以下(发病中位年龄为12.2岁)的系统性红斑狼疮(SLE)患者(45名女孩和10名男孩)进行了回顾性研究。临床表现与既往系列研究相似,但非典型表现很常见。某些不寻常的表现(如孤立性造血异常)经常出现,在某些情况下会导致诊断延迟数年。SLE的美国风湿病学会(ARA)临床分类在儿童和成人中的频率不同。我们观察到许多患者淋巴细胞计数降低,其他患者出现肝酶水平升高。在接受回顾的55例患者中,9例死亡,8例失访。其余患者中,在中位随访8.8年后,21例患有轻至中度疾病,17例患有非活动性或轻度活动性SLE。在严重病例中,使用皮质类固醇和/或细胞毒性药物后,获得了良好的预后。我们累积的5年和10年生存率分别为92%和85%,等于或超过既往儿童SLE报告中的生存率。